VANCOUVER, British Columbia - s4story -- ROOEY Imaging Technology Corp. continues advancing development of its AI-driven diagnostic platform as the medical imaging sector undergoes accelerated technological transformation. Industry analysis estimates the global market for AI in medical imaging at roughly USD 1.6 billion in 2025, with projections indicating expansion to nearly USD 13 billion by 2032, reflecting annual growth exceeding 30 percent. Increasing imaging volumes drive these trends, the need for greater diagnostic accuracy, and the growing role of artificial intelligence in assisting radiologists and oncologists in complex interpretation tasks.

Within this evolving landscape, healthcare systems are increasingly integrating digital collaboration tools and remote diagnostics. Telemedicine adoption continues to expand, enabling specialists to support clinical teams across geographically distributed healthcare facilities. ROOEY Imaging Technology Corp. is advancing the development of capabilities to support this shift, including automated lesion detection, malignancy prediction models, standardized imaging workflows, and real-time collaboration tools to improve consistency in diagnostic decision-making across diverse clinical environments.

More on S For Story

• Veteran Launches GTG Energy: Nicotine-Free Pouch as Americans Rethink Addiction, Focus, and What Fuels Performance
• RecallSentry™ App Launch — Your Home Safety Hub — Free on iOS & Android
• Award-Winning Director Crystal J. Huang's Under-$50K Film "The Ritual House" Wins Best Horror Feature at Golden State Film Festival
• Grads aren't getting hired — here's what we're doing about it
• K2 Integrity Enhances Technology Capabilities Through Acquisition of Leviathan Security Group

Additional development work is focusing on interoperability with clinical systems, predictive analytics, automated reporting, and augmented-reality-enabled visual annotations that support collaborative interpretation of imaging data. As ROOEY Imaging Technology Corp. refines these capabilities, the company continues aligning its platform architecture with broader industry efforts to modernize cancer diagnostics while improving access to specialized expertise across both major medical centers and underserved healthcare regions.

About ROOEY Imaging Technology Corp.: ROOEY is a forward-thinking healthcare technology company specializing in advancing the detection and diagnosis of cancer through sophisticated AI-driven solutions. Learn more at https://rooeytech.com/.